$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Genital Herpes Global Clinical Trials Review, H1, 2016
[Published by Global Data]

Published by Global Data: 29 Feb 2016 | 18133 | In Stock
Related Topics: Clinical Trials

Introduction

Genital Herpes Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Genital Herpes Global Clinical Trials Review, H1, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Genital Herpes to Infectious Disease Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Genital Herpes to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Genital Herpes Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Latest Clinical Trials News on Genital Herpes 30

    Jan 29, 2016: Genocea Commences Dosing in Phase 2b Study for Genital Herpes Treatment, GEN-003 30

    Clinical Trial Profile Snapshots 31

    Appendix 69

    Abbreviations 69

    Definitions 69

    Research Methodology 70

    Secondary Research 70

    About GlobalData 71

    Contact Us 71

    Disclaimer 71

    Source 72

List Of Tables
in Genital Herpes Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Tables

Genital Herpes Therapeutics, Global, Clinical Trials by Region, 2016* 6

Genital Herpes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Genital Herpes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Genital Herpes Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10

Genital Herpes Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Genital Herpes Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Genital Herpes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13

Genital Herpes Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14

Proportion of Genital Herpes to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15

Genital Herpes Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Genital Herpes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Genital Herpes to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18

Genital Herpes Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Genital Herpes Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Genital Herpes Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Genital Herpes Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Genital Herpes Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Genital Herpes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Genital Herpes Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Genital Herpes Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Genital Herpes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Genital Herpes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Genital Herpes Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Figures

Genital Herpes Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Genital Herpes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Genital Herpes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Genital Herpes Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 10

Genital Herpes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Genital Herpes Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Genital Herpes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13

Genital Herpes Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14

Proportion of Genital Herpes to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15

Genital Herpes Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Genital Herpes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Genital Herpes to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18

Genital Herpes Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Genital Herpes Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Genital Herpes Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Genital Herpes Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Genital Herpes Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Genital Herpes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Genital Herpes Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Genital Herpes Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Genital Herpes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Genital Herpes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 70

Additional Details

Publisher

Global Data

Publisher Information

Reference

18133 | GDHC3246CTIDB

Number of Pages

72

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Genital Herpes - Epidemiology Forecast To 2023
DelveInsight “Genital Herpes - Epidemiology Forecast To 2023” provides an overview of the epidemiolo...
31 May 2017 by Delve Insight USD $2,750 More Info
Genital Herpes-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Genital Herpes - Market Ins...
30 May 2017 by Delve Insight USD $4,950 More Info
Genital Herpes-Pipeline Insights, 2017
DelveInsight’s, “ Genital Herpes-Pipeline Insights, 2017”, report provides in depth insights on the ...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2017
DelveInsight’s, “ Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2017”, report provides in...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landsc...
30 May 2017 by Delve Insight USD $2,000 More Info
Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and...
30 May 2017 by Delve Insight USD $2,000 More Info
Genital Herpes - Pipeline Review, H1 2017
Genital Herpes - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and He...
22 Mar 2017 by Global Markets Direct USD $2,000 More Info
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016SummaryGlobalData's cli...
29 Feb 2016 by Global Data USD $2,500 More Info
Genital Herpes Treatment Market: By Product type (Acyclovir, Famciclovir, Valacyclovir), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Drug stores) & Geography -Forecast (2016-2021)
General herpes is categorised as a sexually transmitted disease/infection (STI) which is caused by h...
18 Feb 2016 by USD $5,250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Genital Herpes Global Clinical Trials Review, H1, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...